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    Cyclin-dependent kinase 5 (CDK5), a serine/threonine kinase, was originally 
identified as a member of the cyclin-dependent kinase family based on sequence 
homology. CDK5 is activated by p35 and p39 whose expression are found almost 
exclusively in the nervous system (both CNS and PNS). Thus, CDK5 plays an 
important role in nerves system including regulating neurotransmitter releasing, 
neuronal development, neuron apoptosis and so on. The research of CDK5 has been 
concerned about the discovery and identification of its substrates. Up to now, about 
forty substrates of CDK5 have been identified. As a proline dependent kinase, CDK5 
can phosphorylate proteins that contain the motif of (S/T)PX(H/K/R). Based on this 
motif, by SILAC-phosphoproteomic analysis, we identified BAG3 as a new CDK5 
substrate.  
    Bcl2-associated athanogene 3 (BAG3) protein is a member of BAG family of 
co-chaperones that interacts with the ATPase domain of the heat shock protein Hsp70 
and Bcl-2 through BAG domain (110–124 amino acids). BAG3 is constitutively 
present in several cell types, including cardiomyocytes and skeletal muscle cells, in 
which the protein appears to contribute to cell resistance to mechanical stress. As an 
anti-apoptotic protein, BAG3 is expressed in several tumor types. In different tumor 
contexts, BAG3 protein was reported to sustain cell survival, resistance to therapy. 
These multifaceted interactions underlie BAG3 ability to modulate major biological 
processes in apoptosis, development, cytoskeleton organization and autophagy, 
thereby mediating cell adaptive responses to stressful stimuli. Recently, a growing 
body of evidence indicates that BAG3 also expressed in nervous system, especially in 
the cerebral cortex and hippocampus. We further found that the expression of BAG3 
in astrocyte is much higher than in neuron, microglia. Considering little is known 
about BAG3 in nervous system, especially in astrocyte，our research focus on the 
phosphorylation of BAG3 by CDK5 and its involvement in function of astrocyte in 
















We identified that CDK5 can phosphorylate BAG3 on its ser291 site .The 
phosphorylation of Ser291 of BAG3 increases its protein stability , and decreases its 
interaction with Bcl-2. The phosphorylation of Ser291 of BAG3 do not affect its 
subcellular localization and the interaction with Hsp-70. Since BAG3 level in 
astrocytes is much higher than other nervous cells, we focused on the regulation and 
function of CDK5-BAG3 signaling axis in astrocyte by using primary astrocyte 
culture, astroglioma, neurodegenerative diseases models. The current study contribute 
to deeply understanding the role of CDK5 in the nervous system especially in 
astrocyte, and also benefit to develop new targets for prevent and treatment of 
neurodegenerative diseases, such as Alzheimer's disease. 
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英文缩写 英文全名 中文名称 
AD Alzheimer’s disease 老年性痴呆症；阿尔茨海默症 
CDK5 Cyclin-Dependent Kinase 5 细胞周期依赖性蛋白激酶5 
Aβ β-amyloid β淀粉样蛋白 
APP β-amyloid precursor protein β淀粉样蛋白前体蛋白 
BAG3 Bcl-2-associated athanogene3 Bcl-2相关的永生化基因3 
cDNA Complementary DNA 互补脱氧核糖核酸 
PBS Phosphate-buffered saline 磷酸盐缓冲液 
PCR Polymerase Chain Reaction 聚合酶链式反应 
PS-1 Presenilin-1 早老素-1 
Caspase Cysteinlyaspartatespecific protease 半胱氨酸天冬氨酸特异性蛋白酶
家族 
CHX Cycloheximide 放线菌酮素 
OGD Oxygen Glucose Deprivation 糖氧剥夺 
DNA deoxyribonucleic acid 脱氧核糖核酸 
NMDA N-methyl-D-aspartic acid N-甲基-D-天冬氨酸 
MEF2 Myocyte Enhancer Factor 2 肌细胞增强因子2 
CDKs Cyclin Dependent Kinase 细胞周期依赖性蛋白激酶 
CDK1 Cyclin Dependent Kinase1 细胞周期依赖性蛋白激酶1 
Hsp-70 The 70 kDa heat shock protein 热休克蛋白70 
Bcl-2 B-cell lymphoma/ leukemia-2 B-细胞淋巴瘤/白血病-2 
GFAP Glial Fibrillary Acidic Protein 胶质纤维酸性蛋白 
NF-kB nuclear factor kappa B 核转录因子 
IL-1β Interleukin-1β 白介素1-β  
IL-6 Interleukin-6 白介素6 
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1.1 CDK5概述     
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